Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Minerva Ginecologica|February 25, 2005
From gene therapy to virotherapy for ovarian cancerM A Stoff-Khalili, P Dall, D T CurielCancer Gene Therapy|January 18, 2006
Gene therapy for carcinoma of the breastM A Stoff-Khalili, P Dall, D T CurielImmunopharmacology and Immunotoxicology|December 28, 2006
A pilot study of an anti-MRSA bio-engineered lacteal complex (anti-MRSA BLC) in a murine septicemia modelJesse A Stoff, David E Nix, D W DeYoungOncogene|November 22, 2005
Oncolytic adenoviruses - selective retargeting to tumor cellsJ Michael Mathis, Mariam A Stoff-Khalili, David T CurielMolecular Cancer Therapeutics|March 21, 2006
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenovirusesSvetlana Komarova, Yosuke Kawakami, Mariam A Stoff-Khalili, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2005
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cellsPeter Dall, Isabell Herrmann, Bettina Durst, et al.The British Journal of Oral & Maxillofacial Surgery|August 28, 2017
Distance-dependent accuracy in Le Fort I maxillary repositioning proceduresT Dreiseidler, L Ritter, M Zirk, et al.Gene Therapy|July 22, 2005
A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapyM A Stoff-Khalili, A A Rivera, J N Glasgow, et al.The Open Gene Therapy Journal|October 17, 2009
Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus VectorsMeredith A Preuss, Joel N Glasgow, Maaike Everts, et al.Journal of Reproductive Immunology|November 11, 2008
Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometriumA P Hess, A Schanz, D M Baston-Buest, et al.Pageof 4